BackHeartBeam Overview
HeartBeam Inc

HeartBeam Target Price

Analysts' average 12-month price target for HeartBeam is $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.5

Average Target Price

$2.00297.6% upside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-14Maxim Group$2297.6% upsideOpen
2025-12-11H.C. WainwrightYi Chen$5.5993.4% upsideOpen
2025-12-10UBSYi Chen$5.5993.4% upsideOpen
2025-12-08H.C. Wainwright$2.5397% upsideOpen
2025-10-31Roth Capital$4695.2% upsideOpen
2022-12-02Industrial Alliance Securities$101888.1% upsideOpen

HeartBeam (BEAT) FAQ

HeartBeam (BEAT) currently reports a target price of $2. Use the charts on this page to explore HeartBeam's target price history and peer comparisons.

Analysts' average 12-month price target for HeartBeam is $2, about 297.6% upside from the current share price of $0.5. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $2, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HeartBeam, and consider following BEAT for alerts when major investors trade the stock.

HeartBeam is classified in the Healthcare sector. On target price, it currently shows $2. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BEAT with unrelated industries.